keyword
https://read.qxmd.com/read/38238822/retraction-note-exosomal-lncrna-hnf1a-as1-affects-cisplatin-resistance-in-cervical-cancer-cells-through-regulating-microrna-34b-tuft1-axis
#21
Xiaoqiong Luo, Jingxi Wei, Feng-Lian Yang, Xiao-Xia Pang, Feng Shi, Yu-Xia Wei, Bi-Yun Liao, Jun-Li Wang
No abstract text is available yet for this article.
January 18, 2024: Cancer Cell International
https://read.qxmd.com/read/38227115/exosomal-noncoding-rnas-as-noninvasive-biomarkers-in-bladder-cancer-a-diagnostic-meta-analysis
#22
JOURNAL ARTICLE
Liming Zhao, Jun Li, Zhongguang Xue, Jinfeng Wang
BACKGROUND: In view of discordance consisting in different reports, a meta-analysis was conducted to comprehensively evaluate the diagnostic efficacy of exosomal noncoding RNAs (ncRNAs) in blood and urine in the detection of bladder cancer. METHODS: Eligible studies were acquired by systematic retrieval through PubMed, Cochrane Library, and Embase. The pooled diagnostic efficacy was appraised by reckoning the area under the summary receiver operating characteristic (SROC) curve...
January 16, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/38225339/ascites-exosomal-lncrna-plade-enhances-platinum-sensitivity-by-inducing-r-loops-in-ovarian-cancer
#23
JOURNAL ARTICLE
Hanyuan Liu, Sisi Deng, Xuelin Yao, Yi Liu, Lili Qian, Yingying Wang, Tianjiao Zhang, Ge Shan, Liang Chen, Ying Zhou
Cisplatin resistance is a major cause of therapeutic failure in patients with high-grade serous ovarian cancer (HGSOC). Long noncoding RNAs (lncRNAs) have emerged as key regulators of human cancers; however, their modes of action in HGSOC remain largely unknown. Here, we provide evidence to demonstrate that lncRNA Platinum sensitivity-related LncRNA from Ascites-Derived Exosomes (PLADE) transmitted by ascites exosomes enhance platinum sensitivity in HGSOC. PLADE exhibited significantly decreased expression in ascites exosomes and tumor tissues, as well as in the corresponding metastatic tumors from patients with HGSOC cisplatin-resistance...
January 15, 2024: Oncogene
https://read.qxmd.com/read/38174205/emerging-applications-of-liquid-biopsies-in-ovarian-cancer
#24
REVIEW
Urvi S Chauhan, Mangesh G Kohale, Neha Jaiswal, Rashmi Wankhade
Liquid biopsy is a new diagnostic tool in precision oncology that can be used as a complementary or alternative method to surgical biopsies. It is a cutting-edge sampling technique that examines distinct cancer components, such as exosomes and circulating tumor cells discharged into the peripheral circulation, to identify tumor biomarkers through various methods, including polymerase chain reaction (PCR). Liquid biopsy has several benefits, including its non-invasiveness and practicality, which permit serial sampling and long-term monitoring of dynamic tumor changes...
December 2023: Curēus
https://read.qxmd.com/read/38168631/lncrna-hoxc-as2-regulates-tumor-associated-macrophage-polarization-through-the-stat1-socs1-and-stat1-ciita-pathways-to-promote-the-progression-of-non-small-cell-lung-cancer
#25
JOURNAL ARTICLE
Cunli Yin, Jing Li, Siru Li, Xi Yang, Yingchun Lu, Chunyu Wang, Bin Liu
Tumor-associated macrophages (TAMs) mainly exhibit the characteristics of M2-type macrophages, and the regulation of TAM polarization is a new target for cancer therapy, among which lncRNAs are key regulatory molecules. This study aimed to explore the effects of lncRNA-HOXC-AS2 on non-small cell lung cancer (NSCLC) by regulating TAM polarization. THP-1 cells were used to differentiate into macrophages, and TAMs were obtained by coculture with A549 cells. The M1/M2 cell phenotype and HOXC-AS2 expression were detected, and A549-derived exosomes (A549-exo) were used to elucidate the effects of A549 on macrophage polarization and HOXC-AS2 expression...
December 31, 2023: Cellular Signalling
https://read.qxmd.com/read/38116886/lncrna-uca1-promotes-tumor-progression-by-targeting-smarcd3-in-cervical-cancer
#26
JOURNAL ARTICLE
Lanfen An, Kejun Dong, Shuqi Chi, Sitian Wei, Jun Zhang, Zhicheng Yu, Qian Zhang, Tangansu Zhang, Shuangshuang Cheng, Rui Shi, Zhishan Jin, Xing Zhou, Yingchao Zhao, Hongbo Wang
Long noncoding RNA urothelial carcinoma associated 1 (UCA1) has been identified as a key molecule in human cancers. However, its functional implications remain unspecified in the context of cervical cancer (CC). This research aims to identify the regulatory mechanism of UCA1 in CC. UCA1 was identified through microarray and confirmed through a quantitative real-time polymerase chain reaction. Proteins that bind with UCA1 were recognized using RNA pull-down assays along with RNA immunoprecipitation. Ubiquitination assays and coimmunoprecipitation were performed to explore the molecular mechanisms of the SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 3 (SMARCD3) downregulated in CC...
December 20, 2023: Molecular Carcinogenesis
https://read.qxmd.com/read/38097132/exosomal-lnccrla-is-predictive-for-the-evolvement-and-development-of-lung-adenocarcinoma
#27
JOURNAL ARTICLE
Shuai Lin, Chenyang He, Lingqin Song, Liangzhang Sun, Renyang Zhao, Weili Min, Yang Zhao
Lung adenocarcinoma, the most common histological subtype of non-small cell lung cancer, exhibits heterogeneity that enables adaptability, limits therapeutic success, and remains incompletely understood. Our team uncovers that lncRNA related to chemotherapy resistance in lung adenocarcinoma (lncCRLA) is preferentially expressed in lung adenocarcinoma cells with the mesenchymal phenotype. lncCRLA can not enhance chemotherapy resistance in lung adenocarcinoma due to its binding to RIPK1 in exosomes, which is released into intercellular media and transferred by exosomes from mesenchymal-like to epithelial-like cells...
December 12, 2023: Cancer Letters
https://read.qxmd.com/read/38072970/novel-lncrna-gm33149-modulates-metastatic-heterogeneity-in-melanoma-by-regulating-the-mir-5623-3p-wnt-axis-via-exosomal-transfer
#28
JOURNAL ARTICLE
Yan Chen, Yu-Han Zhang, Jie Li, Lei Shi, Jia-Cheng Xie, Xue Han, Yu-Ting Chen, Meng Xiang, Bo-Wen Li, H Rosie Xing, Jian-Yu Wang
The high mortality rate associated with melanoma primarily results from metastasis and recurrence. However, the precise mechanisms driving these processes remain poorly understood. Intercellular communication between cancer cells and non-cancer cells significantly influences the tumor microenvironment and plays a crucial role in metastasis. Therefore, our current study aims to investigate the role and mechanism of long non-coding RNAs (lncRNAs) in regulating the interaction between melanoma cancer stem cells (CSCs) and non-CSCs during the metastatic colonization process...
December 11, 2023: Cancer Gene Therapy
https://read.qxmd.com/read/38048862/exosome-shuttled-fto-from-bm-mscs-contributes-to-cancer-malignancy-and-chemoresistance-in-acute-myeloid-leukemia-by-inducing-m6a-demethylation-a-nano-based-investigation
#29
JOURNAL ARTICLE
Ruirui Kou, Tian Li, Caizhu Fu, Duanfeng Jiang, Yue Wang, Jie Meng, Ruilan Zhong, Changjiu Liang, Min Dong
Although bone marrow mesenchymal stem cells (BM-MSCs)-derived exosomes have been reported to be closely associated with acute myeloid leukemia (AML) progression and chemo-resistance, but its detailed functions and molecular mechanisms have not been fully delineated. Besides, serum RNA m6A demethylase fat mass and obesity-associated protein (FTO)-containing exosomes are deemed as important indicators for cancer progression, and this study aimed to investigate the role of BM-MSCs-derived FTO-exosomes in regulating the malignant phenotypes of AML cells...
December 2, 2023: Environmental Research
https://read.qxmd.com/read/38035042/explorrnet-an-interactive-web-tool-to-explore-stage-wise-mirna-expression-profiles-and-their-interactions-with-mrna-and-lncrna-in-human-breast-and-gynecological-cancers
#30
JOURNAL ARTICLE
Ankita Lawarde, Edris Sharif Rahmani, Adhiraj Nath, Darja Lavogina, Jana Jaal, Andres Salumets, Vijayachitra Modhukur
BACKGROUND: MicroRNAs (miRNAs) are key regulators of gene expression that have been implicated in gynecological and breast cancers. Understanding the cancer stage-wise expression patterns of miRNAs and their interactions with other RNA molecules in cancer is crucial to improve cancer diagnosis and treatment planning. Comprehensive web tools that integrate data on the transcriptome, circulating miRNAs, and their validated targets to derive beneficial conclusions in cancer research are lacking...
March 2024: Non-Coding RNA Research
https://read.qxmd.com/read/38021786/an-exosome-related-long-non-coding-rna-lncrna-based-signature-for-prognosis-and-therapeutic-interventions-in-lung-adenocarcinoma
#31
JOURNAL ARTICLE
Jinghong Li, Junhua Wang, Zhihong Chen, Pan Hu, Xiaodan Zhang, Xiaojun Guo, Xiao Zhu, Yongmei Huang
Background The poor prognosis of lung adenocarcinoma (LUAD) has been confirmed by a large number of studies, so it is necessary to construct a prognosis model. In addition, exosome is closely related to tumors, but there are few studies on exosome-related long non-coding RNA (lncRNA) (ExolncRNA). Methods In this study, we designed a prognostic model, exosome-related lncRNA-based signature (ExoLncSig), using ExolncRNA expression profiles of LUAD patients from The Cancer Genome Atlas (TCGA). ExolncRNAs were identified through univariate and multivariate and Lasso analyses...
October 2023: Curēus
https://read.qxmd.com/read/38020052/the-emerging-roles-of-exosomal-mirnas-in-breast-cancer-progression-and-potential-clinical-applications
#32
REVIEW
Jie Li, Dejiao He, Yajun Bi, Shengxuan Liu
Breast cancer remains the leading malignancy in terms of morbidity and mortality today. The tumor microenvironment of breast cancer includes multiple cell types, secreted proteins, and signaling components such as exosomes. Among these, exosomes have a lipid bilayer structure. Exosomes can reflect the biological traits of the parent cell and carry a variety of biologically active components, including proteins, lipids, small molecules, and non-coding RNAs, which include miRNA, lncRNA, and circRNA. MiRNAs are a group of non-coding RNAs of approximately 20-23 nucleotides in length encoded by the genome, triggering silencing and functional repression of target genes...
2023: Breast Cancer: Targets and Therapy
https://read.qxmd.com/read/37993428/pdpn-cafs-facilitate-the-motility-of-oscc-cells-by-inhibiting-ferroptosis-via-transferring-exosomal-lncrna-ftx
#33
JOURNAL ARTICLE
Yaoyin Li, Zeyi Ma, Weiyu Li, Xiaoqing Xu, Peiqi Shen, Si-En Zhang, Bin Cheng, Juan Xia
Cancer-associated fibroblasts (CAFs) are abundant and heterogeneous in tumor microenvironment (TME). Cross-talk between cancer cells and CAFs results in cancer progression. Here, we demonstrated that a distinct cancer-associated fibroblasts subset with podoplanin (PDPN) positive expression (PDPN+ CAFs) was correlated with poor survival in oral squamous cell carcinoma (OSCC). PDPN+ CAFs promoted the progression of OSCC by transferring exosomal lncRNA FTX to OSCC cells. Mechanically, FTX bound to flap endonuclease-1 (FEN1), forming an RNA‒protein complex...
November 22, 2023: Cell Death & Disease
https://read.qxmd.com/read/37990331/tumor-derived-exosomal-linc00881-induces-lung-fibroblast-activation-and-promotes-osteosarcoma-lung-migration
#34
JOURNAL ARTICLE
Xinyu Chang, Qiuyu Tan, Jinwen Xu, Xu Wu, Ying Wang, Yuan Zhang, Hao Zhang, Haijun Liu, Liang Yan
Osteosarcoma (OS) commonly metastasizes to the lung, yet the underlying molecular mechanisms remain poorly understood. Exosomes play a crucial role in tumor migration, including OS lung migration. However, the underlying mechanism by which exosome-derived long non-coding RNAs (lncRNAs) contribute to lung migration in osteosarcoma (OS) remains unclear. This study presents a newly discovered lncRNA, linc00881, derived from OS exosomes. Our study shows that linc00881 promotes the migration of OS cells to the lung and induces the conversion of normal lung fibroblasts into cancer-associated fibroblasts (CAFs)...
November 21, 2023: Cancer Cell International
https://read.qxmd.com/read/37987367/-ladon-a-natural-antisense-transcript-of-nodal-promotes-tumour-progression-and-metastasis-in-melanoma
#35
JOURNAL ARTICLE
Annie Dutriaux, Serena Diazzi, Chiara Bresesti, Sylvie Hardouin, Frédérique Deshayes, Jérôme Collignon, Domenico Flagiello
The TGFβ family member NODAL, repeatedly required during embryonic development, has also been associated with tumour progression. Our aim was to clarify the controversy surrounding its involvement in melanoma tumour progression. We found that the deletion of the NODAL exon 2 in a metastatic melanoma cell line impairs its ability to form tumours and colonize distant tissues. However, we show that this phenotype does not result from the absence of NODAL, but from a defect in the expression of a natural antisense transcript of NODAL , here called LADON ...
November 15, 2023: Non-Coding RNA
https://read.qxmd.com/read/37957486/tumor-cell-derived-exosomes-mediating-hsa_circ_0001739-lncrna-ac159540-1-facilitate-liver-metastasis-in-colorectal-cancer
#36
JOURNAL ARTICLE
Cai-Feng Yue, Ju-Gao Chen, Zi-Yue Li, Lai-Sheng Li, Jie-Rong Chen, Hai-Xia Xie, Bin Zhang, Yun-Miao Guo
BACKGROUND: The current study probed into how tumor cell-derived exosomes (Exos) mediated hsa_circ_0001739/lncRNA AC159540.1 to manipulate microRNA (miR)-218-5p/FTO-N6-methyladenosine (m6A)/MYC signal axis in liver metastasis in colorectal cancer (CRC). METHODS: hsa_circ_0001739 and lncRNA AC159540.1 were identified as the upstream regulator of miR-218-5p using ENCORI and LncBase databases. Expression patterns of miR-218-5p, hsa_circ_0001739, lncRNA AC159540.1, FTO, and MYC were detected, accompanied by loss-and-gain-of function assays to examine their effects on CRC cell biological functions...
November 14, 2023: Cell Biology and Toxicology
https://read.qxmd.com/read/37903800/the-microprotein-encoded-by-exosomal-lncakr1c2-promotes-gastric-cancer-lymph-node-metastasis-by-regulating-fatty-acid-metabolism
#37
JOURNAL ARTICLE
Ke-Gan Zhu, Jiayu Yang, Yuehong Zhu, Qihang Zhu, Wen Pan, Siyu Deng, Yi He, Duo Zuo, Peiyun Wang, Yueting Han, Hai-Yang Zhang
Lymph node metastasis (LNM) is the prominent route of gastric cancer dissemination, and usually leads to tumor progression and a dismal prognosis of gastric cancer. Although exosomal lncRNAs have been reported to be involved in tumor development, whether secreted lncRNAs can encode peptides in recipient cells remains unknown. Here, we identified an exosomal lncRNA (lncAKR1C2) that was clinically correlated with lymph node metastasis in gastric cancer in a VEGFC-independent manner. Exo-lncAKR1C2 secreted from gastric cancer cells was demonstrated to enhance tube formation and migration of lymphatic endothelial cells, and facilitate lymphangiogenesis and lymphatic metastasis in vivo...
October 30, 2023: Cell Death & Disease
https://read.qxmd.com/read/37889101/exosomal-lncrna-neat1-inhibits-nk-cell-activity-to-promote-multiple-myeloma-cell-immune-escape-via-an-ezh2-pbx1-axis
#38
JOURNAL ARTICLE
Qing-Ming Wang, Guang-Yu Lian, Su-Mei Sheng, Jing Xu, Long-Long Ye, Chao Min, Shu-Fang Guo
Exosomal long noncoding RNAs (lncRNAs) derived from cancer cells are implicated in various processes, including cancer cell proliferation, metastasis, and immunomodulation. We investigated the role and underlying mechanism of exosome-transmitted lncRNA NEAT1 in the immune escape of multiple myeloma (MM) cells from natural killer (NK) cells. MM cells and samples from MM patients were obtained. The effects of MM cell-derived exosomes (MM exosomes) and exosomal NEAT1 on the functions of NK cells were evaluated using EdU staining, CCK-8, flow cytometry and ELISA...
October 26, 2023: Molecular Cancer Research: MCR
https://read.qxmd.com/read/37887339/exosc9-initiates-sumo-dependent-lncrna-terra-degradation-to-impact-telomeric-integrity-in-endocrine-therapy-insensitive-hormone-receptor-positive-breast-cancer
#39
JOURNAL ARTICLE
Maram Quttina, Kacie D Waiters, Ashfia Fatima Khan, Samaneh Karami, Anthony S Peidl, Mariam Funmi Babajide, Justus Pennington, Fatima A Merchant, Tasneem Bawa-Khalfe
Long, noncoding RNAs (lncRNAs) are indispensable for normal cell physiology and, consequently, are tightly regulated in human cells. Yet, unlike mRNA, substantially less is known about the mechanisms for lncRNA degradation. It is important to delineate the regulatory control of lncRNA degradation, particularly for lncRNA telomeric repeat-containing RNA (TERRA), as the TERRA-telomere R-loops dictate cell cycle progression and genomic stability. We now report that the exosome complex component Exosc9 degrades lncRNA TERRA in human mammary epithelial cells...
October 20, 2023: Cells
https://read.qxmd.com/read/37884197/macrophage-lncrnas-in-cancer-development-long-awaited-therapeutic-targets
#40
REVIEW
Imene Arab, Jeongkwang Park, Jae-Joon Shin, Hyeung-Seob Shin, Kyoungho Suk, Won-Ha Lee
In the tumor microenvironment, the interplay among macrophages, cancer cells, and endothelial cells is multifaceted. Tumor-associated macrophages (TAMs), which often exhibit an M2 phenotype, contribute to tumor growth and angiogenesis, while cancer cells and endothelial cells reciprocally influence macrophage behavior. This complex interrelationship highlights the importance of targeting these interactions for the development of novel cancer therapies aimed at disrupting tumor progression and angiogenesis. Accumulating evidence underscores the indispensable involvement of lncRNAs in shaping macrophage functionality and contributing to the development of cancer...
October 24, 2023: Biochemical Pharmacology
keyword
keyword
98609
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.